Presentation is loading. Please wait.

Presentation is loading. Please wait.

A hypoallergenic cat vaccine based on Fel d 1–derived peptides fused to hepatitis B PreS  Katarzyna Niespodziana, MSc, Margarete Focke-Tejkl, PhD, Birgit.

Published byGülistan Özek Modified over 5 years ago

Similar presentations

Presentation on theme: "A hypoallergenic cat vaccine based on Fel d 1–derived peptides fused to hepatitis B PreS  Katarzyna Niespodziana, MSc, Margarete Focke-Tejkl, PhD, Birgit."— Presentation transcript:

1 A hypoallergenic cat vaccine based on Fel d 1–derived peptides fused to hepatitis B PreS 
Katarzyna Niespodziana, MSc, Margarete Focke-Tejkl, PhD, Birgit Linhart, PhD, Vera Civaj, Katharina Blatt, Peter Valent, MD, Marianne van Hage, MD, Hans Grönlund, PhD, Rudolf Valenta, MD  Journal of Allergy and Clinical Immunology  Volume 127, Issue 6, Pages e6 (June 2011) DOI: /j.jaci Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

2 Fig 1 Construction of PreS fusion proteins. A, Chains 1 and 2 of Fel d 1 with peptides indicated. aa, Amino acid. B, Ribbon representation of Fel d 1 with peptides highlighted in different colors. C, PreS fusion proteins containing peptide 1 (P1; PreS-2xP1) or peptide 5 (P5; PreS-2xP5) at the N- and C-termini, as well as PreS-P1-P5 with an N-terminal P1 and C-terminal P5 peptide. Hexahistidine tags (6xHis) are at the C-terminal end. Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

3 Fig 2 Purity and immune reactivity of recombinant proteins. Coomassie-stained SDS-PAGE (A) and nitrocellulose blots (B) containing PreS (lane 1), PreS-2xP1 (lane 2), PreS-2xP5 (lane 3), PreS-P1-P5 (lane 4), and rFel d 1 (lane 5) were probed with rabbit preimmune serum (Fig 2, B, right, upper part), anti-P1, anti-P5, anti-PreS (Fig 2, B, left, bottom part), or anti–rFel d 1 (Fig 2, B, right, bottom part) antibodies. Molecular weights in kilodaltons are indicated in the left margin. Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

4 Fig 3 Comparison of allergenic activity of rFel d 1 and PreS fusion proteins in the CD203c basophil activation test. Blood cells from 7 patients with cat allergy (Table 1, nos. 4, 7, 13, 14, 17, 18, and 23) were exposed to PBS (unstim.), anti-IgE, and serial dilutions ( μg/mL) of rFel d 1, PreS-2xP1, PreS-2xP5, or PreS-P1-P5 (x-axes). CD203c expression on basophils was determined by means of FACS analysis. CD203c upregulation is displayed as the stimulation index (y-axes). Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

5 Fig 4 PreS- (A) and rFel d 1–specifc (B) IgG1 responses in mice. Groups of 8 mice each were immunized subcutaneously with the antigen shown at the top of the boxes (PreS-2xP1, PreS-2xP5, PreS-P1-P5, PreS, rFel d 1, and PBS). Serum samples were taken 1 day before each immunization in 3-week intervals (0-12 weeks; x-axes). IgG1 reactivities (OD values, y-axes) were determined by means of ELISA and are displayed as box plots, where 50% of the values are within the boxes and nonoutliers are between the bars. The lines within the boxes indicate the median values. Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

6 Fig 5 Immunization with PreS fusion proteins does not induce allergic sensitization to Fel d 1. A, Sera from mice obtained before (PI) and 3 (1. IS), 6 (2. IS), and 12 (4. IS) weeks after immunization with rFel d 1 (x-axis) were heated at 56°C for different times (30 minutes, 2 hours, or 4 hours) or left untreated (0). These sera were loaded onto RBL and exposed to rFel d 1. B, RBL cells were sensitized with mouse antigen (Ag)–specific sera and stimulated with increasing concentrations of rFel d 1 (x-axis). C, RBL cells were sensitized with different dilutions (1:50, 1:25, and 1:10) of allergen-specific murine sera (x-axis) and stimulated with rFel d 1. D, Sensitized RBL cells (x-axis) were stimulated with PreS-2xP1, PreS-P1-P5, and rFel d 1. In each figure β-hexosaminidase releases are displayed as a percentage of total β-hexosaminidase release on the y-axes. Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

7 Fig 6 Inhibition of rFel d 1–induced CD203c upregulation on basophils from patients with cat allergy by rabbit IgG antibodies. Increasing concentrations of rFel d 1 ( μg/mL) were preincubated with rabbit anti–rFel d 1 or anti–PreS-P1-P5 IgG antibodies or the corresponding preimmune serum. Basophils from 2 patients with cat allergy (Table I, nos. 4 and 7) were then exposed to PBS (unstim.), anti-IgE, and the preincubated mixtures of rFel d 1 (x-axes). Upregulation of CD203c expression on basophils determined by means of FACS analysis is displayed as the stimulation index (y-axes). Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

8 Lymphoproliferative responses of PBMCs from 4 patients with cat allergy to the rFel d 1–derived peptides (1-5). Mean stimulation indices are shown for 5 antigen concentrations: 1 μg/well, 0.5 μg/well, 0.25 μg/well, μg/well, and μg/well. Stimulation indices (SIs) of greater than 2.0 are displayed in gray. Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

9 Boosting of Fel d 1–specific IgG responses in vaccinated mice with isolated peptides. A, Groups of 8 mice each were preimmunized with PreS, followed by 3 immunizations either with PreS-2xP1 (B), PreS-P1-P5 (C), or PreS-2xP5 (D). At week 21, when Fel d 1–specific IgG1 responses decreased, mice were randomized into 2 groups of 4 mice each and boosted either with peptide 1 (P1; white bars) alone or with the PreS-2xP1 fusion protein (black bars). Bars represent Fel d 1–specific IgG1 antibody levels (y-axes; OD values). Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

10 Proliferative responses of splenocytes
Proliferative responses of splenocytes. Displayed are proliferative responses (y-axes; stimulation indices) of splenocytes from immunized mice (top of the boxes, immunogens) that had been boosted with P1 (A) or PreS-2xP1 (B) and were stimulated with medium alone, P1, P5, rFel d 1, or PreS (x-axes). Mean values of triplicates are shown as box plots, where 50% of the values are within the boxes and nonoutliers are between the bars. The lines within the boxes indicate the median values of the groups. Journal of Allergy and Clinical Immunology  , e6DOI: ( /j.jaci ) Copyright © 2011 American Academy of Allergy, Asthma & Immunology Terms and Conditions

Download ppt "A hypoallergenic cat vaccine based on Fel d 1–derived peptides fused to hepatitis B PreS  Katarzyna Niespodziana, MSc, Margarete Focke-Tejkl, PhD, Birgit."

Similar presentations

Usefulness of recombinant γ-gliadin 1 for identifying patients with celiac disease and monitoring adherence to a gluten-free diet  Bharani Srinivasan,

Usefulness of recombinant γ-gliadin 1 for identifying patients with celiac disease and monitoring adherence to a gluten-free diet  Bharani Srinivasan,
Volume 11, Pages (September 2016)

Volume 11, Pages (September 2016)
Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study  Anna.

Sensitization to cat and dog allergen molecules in childhood and prediction of symptoms of cat and dog allergy in adolescence: A BAMSE/MeDALL study  Anna.
Volume 11, Pages (September 2016)

Volume 11, Pages (September 2016)
Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope–based grass pollen allergy vaccine with allergen extract–based vaccines 

Comparison of the immunogenicity of BM32, a recombinant hypoallergenic B cell epitope–based grass pollen allergy vaccine with allergen extract–based vaccines 
Kuan-Wei Chen, PhD, Katharina Blatt, MSc, Wayne R

Kuan-Wei Chen, PhD, Katharina Blatt, MSc, Wayne R
Mapping of conformational IgE epitopes on Phl p 5a by using mimotopes from a phage display library  Brigitte Hantusch, MSc, Sigurd Krieger, TA, Eva Untersmayr,

Mapping of conformational IgE epitopes on Phl p 5a by using mimotopes from a phage display library  Brigitte Hantusch, MSc, Sigurd Krieger, TA, Eva Untersmayr,
Identification and isolation of a Fel d 1–like molecule as a major rabbit allergen  Christiane Hilger, PhD, Stéphanie Kler, MSc, Karthik Arumugam, PhD,

Identification and isolation of a Fel d 1–like molecule as a major rabbit allergen  Christiane Hilger, PhD, Stéphanie Kler, MSc, Karthik Arumugam, PhD,
Modifications to an Fcγ-Fcɛ fusion protein alter its effectiveness in the inhibition of FcɛRI-mediated functions  Lisa Chan Allen, PhD, Christopher L.

Modifications to an Fcγ-Fcɛ fusion protein alter its effectiveness in the inhibition of FcɛRI-mediated functions  Lisa Chan Allen, PhD, Christopher L.
Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema  Sabine Zeller, MSc, Claudio Rhyner, PhD, Norbert Meyer, MD, Peter.

Exploring the repertoire of IgE-binding self-antigens associated with atopic eczema  Sabine Zeller, MSc, Claudio Rhyner, PhD, Norbert Meyer, MD, Peter.
Antigen-driven basophil activation is indicative of early Necator americanus infection in IgE-seronegative patients  Franco H. Falcone, PhD, Gary Telford,

Antigen-driven basophil activation is indicative of early Necator americanus infection in IgE-seronegative patients  Franco H. Falcone, PhD, Gary Telford,
Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening  Theresa Thalhamer, PhD, Heidi Dobias, MSc, Tatjana.

Designing hypoallergenic derivatives for allergy treatment by means of in silico mutation and screening  Theresa Thalhamer, PhD, Heidi Dobias, MSc, Tatjana.
Prediction of IgE-binding epitopes by means of allergen surface comparison and correlation to cross-reactivity  Fabio Dall'Antonia, PhD, Anna Gieras,

Prediction of IgE-binding epitopes by means of allergen surface comparison and correlation to cross-reactivity  Fabio Dall'Antonia, PhD, Anna Gieras,
Frequent occurrence of T cell–mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments  Raffaela Campana, PhD, Katharina.

Frequent occurrence of T cell–mediated late reactions revealed by atopy patch testing with hypoallergenic rBet v 1 fragments  Raffaela Campana, PhD, Katharina.
Determination of allergen specificity by heavy chains in grass pollen allergen–specific IgE antibodies  Elisabeth Gadermaier, PhD, Sabine Flicker, PhD,

Determination of allergen specificity by heavy chains in grass pollen allergen–specific IgE antibodies  Elisabeth Gadermaier, PhD, Sabine Flicker, PhD,
IgE cross-reactivity between the major peanut allergen Ara h 2 and the nonhomologous allergens Ara h 1 and Ara h 3  Merima Bublin, PhD, Maria Kostadinova,

IgE cross-reactivity between the major peanut allergen Ara h 2 and the nonhomologous allergens Ara h 1 and Ara h 3  Merima Bublin, PhD, Maria Kostadinova,
Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy  Margarete Focke-Tejkl, PhD, Milena.

Development and characterization of a recombinant, hypoallergenic, peptide-based vaccine for grass pollen allergy  Margarete Focke-Tejkl, PhD, Milena.
Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy  Raphaela.

Blocking antibodies induced by immunization with a hypoallergenic parvalbumin mutant reduce allergic symptoms in a mouse model of fish allergy  Raphaela.
Skin test diagnosis of grass pollen allergy with a recombinant hybrid molecule  Carine Metz-Favre, MD, Birgit Linhart, PhD, Margarete Focke-Tejkl, PhD,

Skin test diagnosis of grass pollen allergy with a recombinant hybrid molecule  Carine Metz-Favre, MD, Birgit Linhart, PhD, Margarete Focke-Tejkl, PhD,
Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE- mediated hypersensitivity  Oliver T. Burton, PhD, Stephanie L. Logsdon,

Oral immunotherapy induces IgG antibodies that act through FcγRIIb to suppress IgE- mediated hypersensitivity  Oliver T. Burton, PhD, Stephanie L. Logsdon,

Similar presentations

Ads by Google